Contact

Mosaic Prairie Home About Services Policy Timeline Safety & Evidence Politics & Players Contact Policy • research • public debate Ibogaine Rick Perry A former Texas governor and U.S. energy secretary has become one of ibogaine’s most visible political champions—moving the conversation from personal testimony toward questions of evidence, regulation, veteran health, and safety. Personal account is not clinical proof. The central distinction A political advocate can change attention—not the evidence standard. Ibogaine is a psychoactive alkaloid associated with the root bark of Tabernanthe iboga . Its basic history and pharmacology are summarized in the ibogaine reference overview , while U.S. law still places the substance in Schedule I. Rick Perry’s public experience in Mexico and later advocacy have given an unusual bipartisan profile to a debate often framed around addiction, PTSD, traumatic brain injury, and veterans. That profile matters because it can accelerate interest in research and funding while also making it easier to confuse a compelling personal account with settled medical knowledge. Federal scheduling, cardiac risk, informed consent, clinical monitoring, and the difference between a study pathway and a commercial treatment claim all remain part of the same conversation. What puts this in focus The argument now lives in three places at once. 01 Personal testimony Perry has described a roughly 12-hour experience in Mexico. His account is central to why he speaks publicly about ibogaine, but an individual outcome cannot establish efficacy or safety for others. 02 State investment Texas has become a high-profile site for discussion of research funding and trials connected to veterans and addiction-related indications. A detailed account of that policy push appears in the Texas psychedelic funding story . 03 Formal review Research interest does not remove regulatory limits. The FDA’s investigational new drug process is one route through which a dru

Contact

A direct route, when one is published.